Veterinary Medicines

FLIMABEND 100 MG/G SUSPENSION FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS

Authorised
  • Flubendazole
Download as PDF

Product identification

Medicine name:
FLIMABEND 100 MG/G SUSPENSION FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS
Flimabend 100 mg/g suspensão para administração na água de bebida em galinhas e suínos
Active substance:
  • Flubendazole
Target species:
  • Chicken (broiler)
  • Pig
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Flubendazole
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        3
        day
      • Meat and offal
        4
        day
    • Chicken
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Package description:
  • Cardboard box containing 2 sachets of 20 g suspension for use in drinking water
  • Cardboard box containing 6 containers of 750 g suspension for use in drinking water
  • Cardboard box containing 4 containers of 750 g suspension for use in drinking water
  • Cardboard box containing 25 sachets of 100 g suspension for use in drinking water
  • Cardboard box containing 5 sachets of 100 g suspension for use in drinking water
  • Cardboard box containing 1 sachet of 100 g suspension for use in drinking water
  • Cardboard box containing 24 sachets of 50 g suspension for use in drinking water
  • Cardboard box containing 2 sachets of 50 g suspension for use in drinking water
  • Cardboard box containing 24 sachets of 20 g suspension for use in drinking water

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 639/01/12DFVPT
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0242/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 4/12/2023
Updated on: 5/12/2023
Download